Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Current Assets (2016 - 2025)

Historic Current Assets for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $53.4 million.

  • iBio's Current Assets rose 54337.35% to $53.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $53.4 million, marking a year-over-year increase of 54337.35%. This contributed to the annual value of $9.7 million for FY2025, which is 3797.22% down from last year.
  • As of Q4 2025, iBio's Current Assets stood at $53.4 million, which was up 54337.35% from $50.8 million recorded in Q3 2025.
  • iBio's 5-year Current Assets high stood at $107.2 million for Q1 2021, and its period low was $6.1 million during Q1 2025.
  • Its 5-year average for Current Assets is $43.2 million, with a median of $37.2 million in 2022.
  • In the last 5 years, iBio's Current Assets skyrocketed by 94040.18% in 2021 and then tumbled by 8312.07% in 2025.
  • Quarter analysis of 5 years shows iBio's Current Assets stood at $67.5 million in 2021, then plummeted by 43.35% to $38.2 million in 2022, then tumbled by 48.48% to $19.7 million in 2023, then plummeted by 57.87% to $8.3 million in 2024, then soared by 543.37% to $53.4 million in 2025.
  • Its Current Assets was $53.4 million in Q4 2025, compared to $50.8 million in Q3 2025 and $9.7 million in Q2 2025.